THALOMID
Live / Registered — Registered and renewed (as of 25 Jan 2018)
What this means for you
Registered since 30 Dec 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Dec 2018).
Record
- Serial number
- 77489356
- Registration number
- 3554067
- Mark type
- Design + words
- Filed
- 03 Jun 2008
- Published for opposition
- 14 Oct 2008
- Registered
- 30 Dec 2008
- Next maintenance due
- 30 Dec 2018
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations that modulate the immune system
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Jan 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 25 Jan 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 25 Jan 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jan 2018 — TEAS SECTION 8 & 9 RECEIVED
- 30 Dec 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 29 Jul 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Jan 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Jan 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.